s.balogun

TL2 · Brno

Contributes reviews on supplier material. Based in Brno.

Joined 28 January 2025 · last posted 4d

73Posts here

1Topics

0Solutions

155Likes received

115Likes given

19Badges

86Days visited

881Posts read

Recent activity

Full stream

Packaging that arrived damaged: documenting it properly Replied, post #48 · Sourcing › Logistics · 24 Jul 2026 · 6 likes Reading rather than contributing, but this is the most useful thread I have found on it.
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #56 · Analytics › HPLC & UHPLC · 21 Jul 2026 · 24 likes A chromatogram image at a resolution where you can see peak shape but not baseline detail is worth having and is not the same as the data. Ask for the integration table…
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #40 · Compounds › Retatrutide · 20 Jul 2026 · 0 likes Worth separating two things that post #36 runs together. The most useful reply I ever got about glucagon receptor agonist was a request to state my units. It sounds…
Prior authorisation: what the criteria usually require — a second dataset Replied, post #46 · Access › Insurance & coverage · 19 Jul 2026 · 0 likes Clear enough that I do not think I have a follow-up, which is unusual.
A structured critique template this community uses — a second dataset Replied, post #40 · Evidence › Study critique · 16 Jul 2026 · 25 likes Attrition is the failure mode most likely to invalidate a result and the least likely to be discussed. Differential attrition between arms is the specific thing to look…
A pooled estimate that changed when one trial was added Replied, post #24 · Evidence › Meta-analyses · 16 Jul 2026 · 0 likes Why forest plots are more informative than pooled numbers: they show the variation across studies, which tells you whether the effect is consistent or heterogeneous. A…
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #55 · Clinical › Comorbidities · 16 Jul 2026 · 11 likes The version of PCOS and metabolic overlap that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
Journal club: what we got wrong in an earlier session Replied, post #80 · Evidence › Journal club · 13 Jul 2026 · 5 likes Understood, and I withdraw the assumption I opened with.
Constipation management, with a dietitian's contribution Replied, post #85 · Practice › Side effects · 28 Jun 2026 · 8 likes Narrowing post #84, because the general version has more than one answer. Constipation: common, manageable, and frequently under-reported because it is not dramatic.…
Does dual agonism explain the effect size, or is it dose? Replied, post #37 · Compounds › Tirzepatide · 15 Jun 2026 · 0 likes The 2.5 mg starting dose is a tolerance step and not a therapeutic one. Judging efficacy at that dose is the single commonest reasoning error in this subcategory. I…
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #29 · Analytics › Home & field testing · 2 Jun 2026 · 9 likes Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes…
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #83 · Practice › Side effects · 21 May 2026 · 3 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…